Cyclin L2 is a critical HIV dependency factor in macrophages that controls SAMHD1 abundance

George Boateng Kyei1, Xiaogang Cheng1, Rashmi Ramani1

  • 1Department of Medicine, Washington University School of Medicine, St. Louis, MO 63110, USA.

Cell Host & Microbe
|December 24, 2014
PubMed

Insights

HIV-1 replication in macrophages is supported by cyclin L2, which controls levels of the restriction factor SAMHD1 (Sterile alpha motif and HD domain-containing protein 1). Cyclin L2 targets SAMHD1 for degradation, enabling viral spread.

Area of Science:

  • Virology
  • Cell Biology
  • Immunology

Background:

  • The restriction factor SAMHD1 (Sterile alpha motif and HD domain-containing protein 1) inhibits HIV-1 replication in noncycling cells.
  • HIV-2 and SIV utilize the Vpx protein to degrade SAMHD1 via DCAF1, facilitating viral replication.
  • The mechanisms by which HIV-1 replicates in macrophages, despite SAMHD1 presence, remain unclear.

Purpose of the Study:

  • To identify host factors enabling HIV-1 replication in macrophages.
  • To elucidate the role of cyclin L2 in HIV-1 replication within macrophages.

Main Methods:

  • Yeast two-hybrid screening to identify DCAF1-interacting proteins.
  • Gene knockdown experiments to assess the impact of cyclin L2 on HIV-1 replication.
  • Co-immunoprecipitation assays to analyze protein complex formation and degradation pathways.

Main Results:

  • Cyclin L2 was identified as a DCAF1-interacting protein essential for HIV-1 replication in macrophages.
  • Knockdown of cyclin L2 significantly attenuated HIV-1 replication in macrophages, an effect dependent on SAMHD1.
  • Cyclin L2 forms a complex with SAMHD1, leading to its proteasomal and DCAF1-dependent degradation.

Conclusions:

  • Cyclin L2 is a critical host factor that promotes HIV-1 replication in macrophages.
  • Cyclin L2 facilitates viral replication by mediating the degradation of the restriction factor SAMHD1.
  • Targeting the cyclin L2-SAMHD1 interaction could offer a novel therapeutic strategy against HIV-1 in macrophages.